Tagrisso (osimertinib) costs $12,750 for a month's supply.
Understanding Tagrisso's Cost
Tagrisso is a specialized medication developed by AstraZeneca, primarily used in the treatment of lung cancer. Its pricing reflects its role as an advanced therapeutic option for this condition.
The monthly cost for Tagrisso is consistent, as detailed below:
| Item | Cost | Frequency |
|---|---|---|
| Tagrisso | $12,750 | Per Month |
This cost covers the supply needed for one full month of treatment. Patients and healthcare providers should be aware of this pricing when considering treatment plans involving Tagrisso.
